Prime-Boost Vaccine Study Shows Modest Effect In Preventing HIV

Global Solutions for Infectious Diseases (“GSID”) announced today that a Phase III clinical trial of an investigational HIV vaccine regimen has been shown to be safe and modestly effective in preventing HIV infection. The double-blind, placebo controlled study was conducted in Thailand among more than 16,000 volunteers.

Source: Prime-Boost Vaccine Study Shows Modest Effect In Preventing HIV